CRISPR Therapeutics AG

NASDAQ:CRSP

42.12 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017201620152014
Assets:
Current Assets:
Cash & Cash Equivalents 298.257389.477211.885923.0311,168.62943.771456.649239.758315.52155.9610.945
Short Term Investments 1,605.5691,304.2151,603.4331,456.098521.713000000
Cash and Short Term Investments 1,903.8261,693.6921,815.3182,379.1291,690.333943.771456.649239.758315.52155.9610.945
Net Receivables 2520000.3050.1440.0990.0882.6263.1570.3390
Inventory 00-11.200000000
Other Current Assets 8.30614.38637.70829.67915.4436.97715.91612.0023.0220.540.023
Total Current Assets 1,937.1321,908.0781,853.0262,417.5131,716.62987.547466.395248.385320.188156.840.968
Non-Current Assets:
Property, Plant & Equipment, Net 277.554305.938320.555312.03593.02572.83218.518.85721.0271.3280
Goodwill 00000000000
Intangible Assets 00.0160.0710.1250.180.2350.2890.3440.3990.4540.509
Goodwill and Intangible Assets 00.0160.0710.1250.180.2350.2890.3440.3990.4540.509
Long Term Investments 01.97353.1316.91316.8485.0413.1633.1543.150.70
Tax Assets 000-16.913-16.848-5.041-3.163-3.154-3.15-0.70
Other Non-Current Assets 27.34813.56616.27522.20418.1416.1383.8323.763.3480.8010.05
Total Non-Current Assets 304.902321.493390.031334.364111.34679.20522.62122.96124.7742.5830.559
Total Assets 2,242.0342,229.5712,243.0572,751.8771,827.9661,066.752489.016271.346344.962159.4231.527
Liabilities & Equity:
Current Liabilities:
Account Payables 14.70938.14727.42814.8169.0945.9445.0691.6394.5691.5840.211
Short Term Debt 17.28843.61331.68424.31622.72416.97800000
Tax Payables 0.4510.4380.1350.72410.4730.5830.4020.3470.0230.0810.011
Deferred Revenue 3.8454.10512.3231.0112.3410.9657.7856.92877.64600
Other Current Liabilities 51.48950.47661.8679.01649.62732.64122.27512.52517.4068.491.924
Total Current Liabilities 87.782108.791121.107119.88394.25957.10627.74614.51121.99810.1552.146
Non-Current Liabilities:
Long Term Debt 206.405223.007228.179212.87250.06744.05000-26.1850
Deferred Revenue Non-Current 014.01212.32312.32311.77611.77657.7856.92877.64675.090
Deferred Tax Liabilities Non-Current 00000000064.5210
Other Non-Current Liabilities 15.7670.9585.9697.3397.6314.39511.29512.07512.472-64.0766.355
Total Non-Current Liabilities 222.172237.977246.471232.53469.47370.22169.07569.00390.118178.3926.355
Total Liabilities 309.954346.768367.578352.417163.732127.32796.82183.514112.116188.5478.501
Equity:
Preferred Stock 00000000064.5216.27
Common Stock 2.6982.4972.4412.3912.2771.8471.5841.241.2160.1810.12
Retained Earnings -1,365.952-999.7-846.09-195.915-573.576-224.711-291.569-125.44-57.083-33.906-8.403
Accumulated Other Comprehensive Income/Loss 1.841.913-15.647-5.067-0.0830.007-0.0080.014-0.026-0.008-0.002
Other Total Stockholders Equity 3,293.4942,878.0932,734.7752,598.0512,235.6161,162.282682.188312.018288.739-64.521-6.27
Total Shareholders Equity 1,932.081,882.8031,875.4792,399.461,664.234939.425392.195187.832232.846-29.097-7.117
Total Equity 1,932.081,882.8031,875.4792,399.461,664.234939.425392.195187.832232.846-29.124-6.974
Total Liabilities & Shareholders Equity 2,242.0342,229.5712,243.0572,751.8771,827.9661,066.752489.016271.346344.962159.4231.527